Agalimmune Ltd.
08504603
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2025
total exemption full
Next accounts due
30/09/2027
Confirmation statement
Last: 25/04/2025
Due 09/05/2026
Industry
Officers
director · Since 08/07/2025
DIRECTOR
BRITISH · ENGLAND · Age 47
Also on 2 other boards
Persons with Significant Control
Former PSCs
Loxbridge Research Llp
Ceased 20/03/2017
Animatrix Capital Llp
Ceased 20/03/2017
Biolinerx Ltd.
Ceased 08/07/2025
Charges0 outstanding
KREOS CAPITAL V (EXPERT FUND) L.P.
KREOS CAPITAL V (EXPERT FUND) L.P.
ANIMATRIX FINANCE LIMITED
CompanyRankvs 752+ SIC 72200 peers58
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£2.8M
Balance sheet strength
Cash
£9k
Cash in the bank
Net Current Assets
-£24.0M
Working capital
Current Assets
£10k
Current Liabilities
£24.0M
Debtors
£429
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.00 | +£2.8M |
| 2024 | 0.00 | +£23.4M |
| 2023 | — | -£23.4M |
| 2022 | 0.02 | +£0 |
| 2021 | 0.04 | +£0 |
| 2020 | 0.05 | +£0 |
| 2019 | 0.06 | — |
Derived from filed accounts. Not audited figures.